Your browser doesn't support javascript.
loading
Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients.
Meazza, Raffaella; Falco, Michela; Marcenaro, Stefania; Loiacono, Fabrizio; Canevali, Paolo; Bellora, Francesca; Tuberosa, Claudia; Locatelli, Franco; Micalizzi, Concetta; Moretta, Alessandro; Mingari, Maria C; Moretta, Lorenzo; Aricò, Maurizio; Bottino, Cristina; Pende, Daniela.
Afiliación
  • Meazza R; Dipartimento delle Terapie Oncologiche Integrate, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Falco M; Dipartimento di Ricerca e Diagnostica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Marcenaro S; Dipartimento di Ricerca e Diagnostica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Loiacono F; Dipartimento delle Terapie Oncologiche Integrate, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Canevali P; Dipartimento di Ricerca e Diagnostica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Bellora F; Dipartimento di Ricerca e Diagnostica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Tuberosa C; Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genoa, Italy.
  • Locatelli F; Dipartimento delle Terapie Oncologiche Integrate, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Micalizzi C; Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genoa, Italy.
  • Moretta A; Dipartimento di Oncoematologia Pediatrica, IRCCS Ospedale Bambino Gesù, Rome, Italy.
  • Mingari MC; Università di Pavia, Pavia, Italy.
  • Moretta L; Dipartimento di Oncoematologia Pediatrica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Aricò M; Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genoa, Italy.
  • Bottino C; Dipartimento delle Terapie Oncologiche Integrate, IRCCS AOU San Martino-IST, Genoa, Italy.
  • Pende D; Dipartimento di Medicina Sperimentale, Università degli Studi di Genova, Genoa, Italy.
Eur J Immunol ; 47(6): 1051-1061, 2017 06.
Article en En | MEDLINE | ID: mdl-28386908
ABSTRACT
X-linked lymphoproliferative disease 1 (XLP1) is an inherited immunodeficiency, caused by mutations in SH2D1A encoding Signaling Lymphocyte Activation Molecule (SLAM)-associated protein (SAP). In XLP1, 2B4, upon engagement with CD48, has inhibitory instead of activating function. This causes a selective inability of cytotoxic effectors to kill EBV-infected cells, with dramatic clinical sequelae. Here, we investigated the NK cell education in XLP1, upon characterization of killer Ig-like receptor (KIR)/KIR-L genotype and phenotypic repertoire of self-HLA class I specific inhibitory NK receptors (self-iNKRs). We also analyzed NK-cell cytotoxicity against CD48+ or CD48- KIR-ligand matched or autologous hematopoietic cells in XLP1 patients and healthy controls. XLP1 NK cells may show a defective phenotypic repertoire with substantial proportion of cells lacking self-iNKR. These NK cells are cytotoxic and the inhibitory 2B4/CD48 pathway plays a major role to prevent killing of CD48+ EBV-transformed B cells and M1 macrophages. Importantly, self-iNKR defective NK cells kill CD48- targets, such as mature DCs. Self-iNKR- NK cells in XLP1 patients are functional even in resting conditions, suggesting a role of the inhibitory 2B4/CD48 pathway in the education process during NK-cell maturation. Killing of autologous mature DC by self-iNKR defective XLP1 NK cells may impair adaptive responses, further exacerbating the patients' immune defect.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Receptores de Células Asesinas Naturales / Familia de Moléculas Señalizadoras de la Activación Linfocitaria / Trastornos Linfoproliferativos Límite: Humans Idioma: En Revista: Eur J Immunol Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Receptores de Células Asesinas Naturales / Familia de Moléculas Señalizadoras de la Activación Linfocitaria / Trastornos Linfoproliferativos Límite: Humans Idioma: En Revista: Eur J Immunol Año: 2017 Tipo del documento: Article País de afiliación: Italia